Nestle Considers Selling L'Oréal Stake
New Nestle boss Laurent Freixe is rumoured to be considering selling his 20% stake in L'Oréal to raise much-needed advertising and marketing investment in hopes of reversing a slide in market share.
The 20.1% stake is currently worth $47 billion, according to Reuters. With the food giant's share price relatively low, selling all or part of the stake could help fund marketing campaigns as well as a share buyback program.
Any size sale would likely have a negative impact on L'Oréal's share price, but Reuters revealed that this could be avoided with a targeted buyback, allowing the Bettencourt family to increase its stake in the French beauty giant.
Looking for chemical products? Let suppliers reach out to you!
2026-06-21
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
L'Oréal to Invest $80 Million in Mexico Factory Expansion
-
L'Oréal's Performance in the First Half of 2025 Was Solid: Growth Across All Business Lines and Continued Improvement in Profit Margins
-
L'Oréal Acquires Professional Hair Care Brand Color Wow
-
L'Oréal May Soon Acquire Medik8 for 1 Billion Euros
-
L'Oréal UK sales hit £1.5 billion
-
L'Oréal's SalonCentric Acquires Concept JP
-
L'Oréal's Quarterly Sales Growth Hit a New Low Since the Epidemic Due to the Weak Chinese Market
-
Sanofi Repurchases 2.3% of L'Oréal Shares
-
L'Oréal acquires Korean skincare brand Dr.G from Swiss conglomerate Migros
-
L'Oréal sells Decléor and Saint-Gervais Mont Blanc to Cospal to streamline portfolio
Recommend Reading
-
BASF and Hannong Chemical Joint Venture Nonionic Surfactant Plant Begins Operation in South Korea
-
Procter & Gamble Raises US Personal Care Prices Due to Tariff Pressure
-
Nouryon Opens New Customer Experience and Innovation Center in Brazil
-
Procter & Gamble Posts Higher Profits on Strong Personal Care Sales and Recovery in China
-
POND GROUP Acquires All Grace, Boosting Cosmetics Market Share by 20%
-
Syndax Q2 Net Loss Widens to $71.8 Million Despite 43 Percent Revenue Surge and New Drug Momentum
-
LANXESS Raises Global 1,6-Hexanediol Prices by 20% as Cost Pressure Begins to Pass Downstream
-
Vertex Shares Plunge 14.4 Percent After Pain Drug Trial Misses Key Target and Study Halt
-
BASF Raises BA and 2-EHA Prices as Acrylic Ester Costs Continue to Move Higher in Asia-Pacific
-
Noom Launches Compounded Wegovy for Weight Loss at $119 Patients See 15 to 20 Percent Reduction